Expression Vectors for Human-Mouse Chimeric Antibodies

Embed Size (px)

Citation preview

  • 8/13/2019 Expression Vectors for Human-Mouse Chimeric Antibodies

    1/6

    BIOT 5031

    Report on

    Expression Vectors forHuman-Mouse ChimericAntibodiesKundnani Deepali Lalchand118743512/2/2013

  • 8/13/2019 Expression Vectors for Human-Mouse Chimeric Antibodies

    2/6

    Expression vectors for Human-Mouse Chimeric Antibodies

    As we know the use of antibodies have vastly increased in the past years and scientists are trying

    to combat various issues in the production of Antibodies and their applications, one of the main

    being the inherent immunogenicity in patients that hinders long term administration in

    immunosuppressive therapy. To reduce these reactions human mouse chimeric antibodies

    containing constant regions of Human antibody and Variable region from organism(murine) with

    an immune response to the desired antigen are used and a system able to rapidly produce high

    levels of recombinant antibody is needed. or e!pressions of engineered "g# in $H%($hinese

    Hamster %varian) cells two systems have been fre&uently utili'ed, one of which is two vector

    system with each "g# chain on separate plasmid and other being one vector system with both

    "g# chains on the same plasmid. "n this study two vector system has been adopted because of

    ease of insertion of se&uences into the vectors and e!pression of variable regions of antibodies in

    different immunoglobin isotypes.

    ecombinant *A technology was used in creating e!pression vectors (p+#$-VHfor heavy

    chain fragments and p+#$-VLfor light chain fragments) derived from pV/dhfr due to

    ease of production of antibodies and being able to co amplify the desired gene with

    H(dihydrofolate reductase) in dhfr$H% cells. pV/ contains V01 promotor which can be

    weakened by deleting its enhancer se&uence by ph ". ph$2V2$3#H polyA was inserted

    into the vectors from pc*A4 which provides a human $ytomegalovirus 5romotor to the gene

    inserted in the 2$ region. Heavy chain vector contains weakened H gene and light chain

    e!pression vector contains *eo which aids the cotransfection of these two vectors in the

  • 8/13/2019 Expression Vectors for Human-Mouse Chimeric Antibodies

    3/6

    mammalian cells. esired constant and variable region genes were obtained by T5$ and

    were inserted into the 2$ regions of respective vectors by using 6ho" endonucleases.

    Transient antibody e!pressions was employed in $%7 cells and stable e!pression in dhfr$H%

    cells by using 8ipofectA2"*-T2 and grown on 2-2 9 :1; $ under #0:< selection

    selection for *eoin the vectors. The secretion of the antibodies was detected by -8"A and

    found to be over : =g>m8.

    ?ith the use of 2T6 (2ethotre!ate) in dhfr

    cells, H gene as a fact amplifies (and co

    amplifies the gene with it) @11/111 folds and finally with a several :11 fold amplification in

    protein production. o 2T6 was added in increasing &uantities of 4 ! :1 < to :12 which

    resulted into coamplification of product gene having h$2V(human cytomegalovirus) promotor

    along with H gene having weak V01 promotor and the production of H$Ab was over 41

    =g>m8 for 2T6 4 ! :1< 2 with a highest production of :11 =g>m8for 2T6 at :12. urther

    screening was done to select a high e!pressing clone from the pools obtained and after 4 rounds

    of screening the production was found to be :11 mg>8 at :12 2T6.

    The methods used for detection made use of both light and heavy chain recognition. -8"A was

    employed to assess the productivity of H$Ab using plates coated with goat antihuman kappa

    light chain antibody and after the sample was let for the reaction between the former antibody

    and H$Ab produced, the signala was detected using #oat Antihuman "g#(c specific)

    pero!idase Antibody. ?estern blot was further used to analyse the weight of recombinanat "g

    chain. irst the molecule was isolated using a column and was detected by 5A#- under

  • 8/13/2019 Expression Vectors for Human-Mouse Chimeric Antibodies

    4/6

    reducing conditions. The molecular weight found were @1 ka for heavy chain and /: ka for

    light chain. These two tests confirmed the correct structure and correct assembly of the heavy

    and light chains in the production of the recombinant "g molecule.

    The e!pressions vectors used in this study have been optimi'ed to ma!imi'e the production of

    the recombinant product by using H amplification system and as the amplification is done in

    the telomeric region, it ensures hereditary stability and weakening of H production aided the

    increase in recombinant proteins at low 2T6 levels (h$2V being a strong promotor). These

    vectors were discovered to to be able to e!press different isotypes of "g as they contain

    restriction sites facilitating the e!change of $ regions. Bse of double selection markers (H

    and *eo) came to an advantage as they may balance the respective chain e!pressions and

    selection with both markers will help deleting pseudoclones. However lack of knowledge of

    events leading to homologous recombination may lead to disproportionate amplification. To

    overcome this aspect, weakened H was included in the heavy chain vector so as to produce

    more of heavy chains to balance the production of both the chains.

    This e!pression system is lesstime consuming and more cost effective in mass production of full

    length antibody molecules in stable pool and the vectors have proved to have following

    characteristicsC ease of e!pression of H$Ab by e!changing variable regions, transient and stable

    e!pression, e!pression of variable regions of various isotypes, balanced e!pression of two chains

    of antibodies and effective amplification and mass production of recombinant antibodies.

  • 8/13/2019 Expression Vectors for Human-Mouse Chimeric Antibodies

    5/6

    References:

    6iong H, an +, 6ing D, -!pression Vectors for Humanmouse $himeric Antibodies (/11@),

    Journal of Biochemistry and Molecular biology, 38-4, pp. 0:00:E

  • 8/13/2019 Expression Vectors for Human-Mouse Chimeric Antibodies

    6/6